Genetic Ablation of Astrocyte-specific Angiotensin II Type 1 Receptors Improves Prognosis of Myocardial Infarction-Induced Heart Failure

被引：0
|
作者：
Isegawa, Kengo
Hirooka, Yoshitaka
Kishi, Takuya
Sunagawa, Kenji
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Heart failure; Central nervous system; Remodeling;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13100
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Olmesartan, an Angiotensin II Receptor Type 1 Antagonist, Suppresses Cytotoxic Myocardial Injury in Autoimmune Heart Failure
    Kishimoto, Chiharu
    Nimata, Masaomi
    Okabe, Taka-aki
    Shioji, Keisuke
    Yuan, Zuyi
    CIRCULATION, 2009, 120 (18) : S891 - S891
  • [32] Olmesartan, an angiotensin II type 1 receptor antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure
    Kishimoto, C.
    Shimada, K.
    Yuan, Z.
    EUROPEAN HEART JOURNAL, 2012, 33 : 864 - 864
  • [33] Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice
    Yan, XH
    Price, RL
    Nakayama, M
    Ito, K
    Schuldt, AJT
    Manning, WJ
    Sanbe, A
    Borg, TK
    Robbins, J
    Lorell, BH
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (05): : H2179 - H2187
  • [34] βARK1 inhibition improves survival and cardiac function in a mouse model of heart failure induced by myocardial infarction
    Suzuki, Y
    Nakano, K
    Sugiyama, M
    Matsumoto, Y
    Imagawa, J
    Ikeda, S
    CIRCULATION, 2002, 106 (19) : 291 - 291
  • [35] Protection of Renal Impairment by Angiotensin II Type 1 Receptor Blocker in Rats with Post-Infarction Heart Failure
    Wen, Zhuzhi
    Cai, Muyan
    Mai, Zun
    Chen, Yangxin
    Geng, Dengfeng
    Wang, Jingfeng
    RENAL FAILURE, 2013, 35 (05) : 766 - 775
  • [36] Pretreatment with KGA-2727, a selective SGLT1 inhibitor, is protective against myocardial infarction-induced ventricular remodeling and heart failure in mice
    Sawa, Yohei
    Saito, Maki
    Ishida, Nanae
    Ibi, Miho
    Matsushita, Naoko
    Morino, Yoshihiro
    Taira, Eiichi
    Hirose, Masamichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2020, 142 (01) : 16 - 25
  • [37] Inhibition of Angiotensin II Signaling on LysM plus Myelomonocytic Cells and Their Depletion Improves Vascular Endothelial Dysfunction in Mice With Heart Failure After Myocardial Infarction
    Rudi, Wolf-Stephan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [38] Exendin-4 inhibits atrial arrhythmogenesis in a model of myocardial infarction-induced heart failure via the GLP-1 receptor signaling pathway
    Chen, Jingjing
    Xu, Shunen
    Wang, Long
    Zhou, Wei
    Li, Ping
    Deng, Na
    Tang, Qian
    Li, Yongkang
    Wu, Lirong
    Chen, Jiulin
    Li, Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (04) : 3669 - 3678
  • [39] Regulation of angiotensin-(1–7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure
    Wen-na Zong
    Xiao-hui Yang
    Xiu-mei Chen
    Hong-juan Huang
    Hong-jian Zheng
    Xiao-yi Qin
    Yong-hong Yong
    Kejiang Cao
    Jun Huang
    Xin-zheng Lu
    Acta Pharmacologica Sinica, 2011, 32 : 1345 - 1350
  • [40] Nox2+myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1
    Molitor, M.
    Rudi, W. S.
    Garlapati, V. S.
    Finger, S.
    Wild, J.
    Knopp, T.
    Karbach, S.
    Ruf, W.
    Muenzel, T.
    Wenzel, P.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3751 - 3751
12345